Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma.

Baretta Z, Guindalini RS, Khramtsova G, Olopade OI. Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma. Clin Breast Cancer. 2013 Apr; 13(2):156-8.

View in: PubMed

subject areas

Adenocarcinoma, Mucinous
Adult
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Breast Neoplasms
Carcinoma, Ductal, Breast
Drug Resistance, Neoplasm
Female
Humans
Immunoenzyme Techniques
Middle Aged
Neoplasm Grading
Neoplasm Staging
Prognosis
Receptor, erbB-2
Receptors, Estrogen
Receptors, Progesterone

authors with profiles

Olufunmilayo Olopade